Gelmann EP - Search Results

1

Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization.

Zhang Y, Glass A, Bennett N, Oyama KA, Gehan E, Gelmann EP. Zhang Y, et al. Among authors: gelmann ep. Cancer. 2004 Jan 15;100(2):300-7. doi: 10.1002/cncr.11886. Cancer. 2004. PMID: 14716764 Free article.

2

Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.

Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP, Nevalainen MT. Li H, et al. Among authors: gelmann ep. Clin Cancer Res. 2005 Aug 15;11(16):5863-8. doi: 10.1158/1078-0432.CCR-05-0562. Clin Cancer Res. 2005. PMID: 16115927

3

Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.

Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP. Asatiani E, et al. Among authors: gelmann ep. Cancer Res. 2005 Feb 15;65(4):1164-73. doi: 10.1158/0008-5472.CAN-04-2688. Cancer Res. 2005. PMID: 15734999

4

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Tan SH, et al. Among authors: gelmann ep. Cancer Res. 2008 Jan 1;68(1):236-48. doi: 10.1158/0008-5472.CAN-07-2972. Cancer Res. 2008. PMID: 18172316

5

High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.

Ruiz C, Oeggerli M, Germann M, Gluderer S, Stocker H, Andreozzi M, Thalmann GN, Cecchini MG, Zellweger T, Stürm S, Koivisto PA, Helin HJ, Gelmann EP, Glass AG, Gasser TC, Terracciano LM, Bachmann A, Wyler S, Bubendorf L, Rentsch CA. Ruiz C, et al. Among authors: gelmann ep. Prostate. 2012 Nov;72(15):1678-87. doi: 10.1002/pros.22521. Epub 2012 Apr 2. Prostate. 2012. PMID: 22473923

6

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.

Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L. Zellweger T, et al. Among authors: gelmann ep. Prostate. 2003 Apr 1;55(1):20-9. doi: 10.1002/pros.10209. Prostate. 2003. PMID: 12640657

7

A pilot trial of chemohormonal therapy for metastatic prostate carcinoma.

Dawson NA, Wilding G, Weiss RB, McLeod DG, Linehan WM, Frank JA, Jacob JL, Gelmann EP. Dawson NA, et al. Among authors: gelmann ep. Cancer. 1992 Jan 1;69(1):213-8. doi: 10.1002/1097-0142(19920101)69:1<213::aid-cncr2820690135>3.0.co;2-v. Cancer. 1992. PMID: 1727665 Clinical Trial.

8

Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.

Gelmann EP, Steadman DJ, Ma J, Ahronovitz N, Voeller HJ, Swope S, Abbaszadegan M, Brown KM, Strand K, Hayes RB, Stampfer MJ. Gelmann EP, et al. Cancer Res. 2002 May 1;62(9):2654-9. Cancer Res. 2002. PMID: 11980664

9

Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers.

Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP. Voeller HJ, et al. Among authors: gelmann ep. Cancer Res. 1997 Oct 15;57(20):4455-9. Cancer Res. 1997. PMID: 9377551

10

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP. Bowen C, et al. Among authors: gelmann ep. Cancer Res. 2000 Nov 1;60(21):6111-5. Cancer Res. 2000. PMID: 11085535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters